Ellagic acid supplementation in patient with irritabe bowel syndrome

The effects of oral supplementation ellagic acid on anti-oxidant status, inflammatory markers, and quality of life in a patient with irritabe bowel syndrome: randomized double-blind clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141025019669N11

Enrollment

Registered

2019-01-12

Start date

2018-12-01

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome with diarrhea

Interventions

Intervention 1: Intervention group: Ellagic acid, a capsule 200 mg per daily for two months, Manufacturer: Supplement Spot. Intervention 2: Control group: A daily placebo capsule containing wheat fl

Eligibility

Sex/Gender

All

Age

19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Men and women with irritable bowel syndrome

Exclusion criteria

Exclusion criteria: Patients with gastrointestinal problems such as celiac disease and infection of the gastrointestinal tract

Design outcomes

Primary

Measure	Time frame
Antioxidant indices. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.;Quality of life. Timepoint: Before intervention and after intervention. Method of measurement: Irritable Bowel Syndrome Quality of Life Questionnaire.;Sleep quality. Timepoint: Before intervention and after intervention. Method of measurement: Petersburg’s sleep quality questionnaire.;Inflammatory factors. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.	—

Measure

Time frame

Antioxidant indices. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.;Quality of life. Timepoint: Before intervention and after intervention. Method of measurement: Irritable Bowel Syndrome Quality of Life Questionnaire.;Sleep quality. Timepoint: Before intervention and after intervention. Method of measurement: Petersburg’s sleep quality questionnaire.;Inflammatory factors. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Khadem Haghighian

Qazvin University of Medical Sciences

khademnut@yahoo.com+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026